Related Experiment Videos
Molecular aspects of Down syndrome
Samikshan Dutta1, Krishnadas Nandagopal, Prasanta Kumar Gangopadhyay
1Manovikas Biomedical Research and Diagnostic Center, 482, Madudah, Plot I24, Sec.J, E.M. Bypass, Kolkata 700 107, India.
Indian Pediatrics
|May 7, 2005
Summary
Down syndrome (DS), a genetic disorder from trisomy 21, is explored. Research investigates gene dosage and genetic imbalance as causes, but molecular aspects and phenotypic changes remain unclear, necessitating further study for effective treatments.
Area of Science:
- Genetics
- Neurobiology
- Developmental Biology
Background:
- Down syndrome (DS) is a genetic disorder primarily caused by trisomy 21.
- It is a leading genetic cause of intellectual disability.
- The molecular mechanisms underlying DS pathogenesis are not fully understood.
Purpose of the Study:
- To discuss the molecular aspects of Down syndrome.
- To explore hypotheses regarding the genetic causes of DS, including gene dosage and genetic imbalance.
- To identify candidate genes potentially involved in DS.
Main Methods:
- Review of existing hypotheses on DS etiology.
- Development and utilization of murine models for DS research.
- Sequencing of human chromosome 21 to identify candidate genes.
Main Results:
- Two main hypotheses regarding DS pathogenesis were considered: increased gene dosage and genetic imbalance.
- Experimental models and chromosome 21 sequencing suggested potential candidate genes.
- The precise relationship between gene number and phenotypic changes in DS remains unexplained.
Conclusions:
- Further research into screening patterns and model systems is needed.
- A deeper understanding of DS etiology is crucial for developing effective therapeutic strategies.
- Continued investigation into the molecular basis of DS is essential for advancing treatment options.